Vector Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vector Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vector Sciences Today - Breaking & Trending Today

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial | Infectious Diseases | JAMA

Published: January 14, 2022

This randomized trial assesses the effect of a single dose of subcutaneous casirivimab and imdevimab antibody combination vs placebo on 28-day progression to sy

Source: jamanetwork.com

Related Topics:

Eteläuomen LäiUnited StatesSouth AfricaVocs VoisVan ElterenMeaganp ObrienPrevention Trial TeamNational Institute Of AllergyMelinda Gates FoundationVector SciencesUniversity Of North CarolinaGilead Sciences IncPrevention NetworkPrevention Network CoPfizer IncMusk FoundationRoche LtdHenrym Jackson FoundationGood Clinical Practices International Council For HarmonisationCenters For DiseaseGilead SciencesRegeneron Pharmaceuticals IncGroup InformationNational Institutes Of HealthDrug Administration